Study Suggests CGM Benefits for Non-Insulin Dependent Type 2 Diabetes Patients

A Dexcom-funded study published in The New England Journal of Medicine indicates that continuous glucose monitors (CGMs) may benefit Type 2 diabetes patients not using insulin. Participants using CGMs showed a greater reduction in hemoglobin A1c levels over 26 weeks compared to those receiving standard care. These findings could prompt the Centers for Medicare and Medicaid Services (CMS) to expand Medicare coverage for CGMs to this patient group.